- Home
- Publications
- Publication Search
- Publication Details
Title
Development of treatment strategies for advanced neuroblastoma
Authors
Keywords
-
Journal
International Journal of Clinical Oncology
Volume 17, Issue 3, Pages 196-203
Publisher
Springer Nature
Online
2012-05-15
DOI
10.1007/s10147-012-0417-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis
- (2012) Fan Yang et al. CANCER BIOLOGY & THERAPY
- Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells
- (2011) Natalie Grinshtein et al. CANCER RESEARCH
- ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
- (2011) J. M. Heuckmann et al. CLINICAL CANCER RESEARCH
- Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group
- (2011) J. G. Villablanca et al. CLINICAL CANCER RESEARCH
- Successful Multifold Dose Escalation of Anti-GD2Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study
- (2011) Brian H. Kushner et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
- (2011) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
- (2011) A. Faisal et al. MOLECULAR CANCER THERAPEUTICS
- A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age
- (2011) Sylvie Monnereau-Laborde et al. PEDIATRIC BLOOD & CANCER
- Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma
- (2011) Muna Qayed et al. PEDIATRIC BLOOD & CANCER
- Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program
- (2011) Richard B. Lock et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program
- (2011) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
- Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program
- (2010) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Finding the Weakness in Cancer
- (2009) Julian Downward NEW ENGLAND JOURNAL OF MEDICINE
- A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)
- (2008) Gilles Vassal et al. EUROPEAN JOURNAL OF CANCER
- Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group
- (2008) Andrew L. Gilman et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- (2008) Andrew DJ Pearson et al. LANCET ONCOLOGY
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program
- (2008) John M. Maris et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program
- (2008) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program
- (2008) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
- Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program
- (2007) John M. Maris et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started